Back to CLDX
Hennion & Walsh Asset Management, Inc. → CLDX
Hennion & Walsh Asset Management, Inc. CLDX Position History
Celldex Therapeutics, Inc.
Quarters held
5
Latest value
$1.5M
Q3 2026
Peak value
$1.8M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $926K |
| Q4 2025 | $1.3M |
| Q1 2026 | $1.5M |
| Q2 2026 | $1.8M |
| Q3 2026 | $1.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.5M | 47.8K | — | — |
| Q2 2026 | $1.8M | 47.1K | — | — |
| Q1 2026 | $1.5M | 47.5K | — | — |
| Q4 2025 | $1.3M | 47.0K | — | — |
| Q3 2025 | $926K | 35.8K | — | — |